{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:04:39Z","timestamp":1772769879385,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2010\/13199-1"],"award-info":[{"award-number":["2010\/13199-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Toxicologic Pathology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.etp.2017.01.004","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T01:01:20Z","timestamp":1485824480000},"page":"213-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Short-term and long-term models of doxorubicin-induced cardiomyopathy in rats: A comparison of functional and histopathological changes"],"prefix":"10.1016","volume":"69","author":[{"given":"Jo\u00e3o Lucas","family":"O\u2019Connell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minna Moreira Dias","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica C.","family":"Campos Pulici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo E.V.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda R.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise M.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedito Carlos","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9lio C.","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubens","family":"Fazan-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos A.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus V.","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.etp.2017.01.004_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1742-7843.2007.00070.x","article-title":"Effect of lycopene on doxorubicin-induced cardiotoxicity: an echocardiographic, histological and morphometrical assessment","volume":"101","author":"Anjos Ferreira","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.etp.2017.01.004_bib0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0046-8177(79)80043-X","article-title":"Some recent advances in cardiac pathology","volume":"10","author":"Billingham","year":"1979","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.etp.2017.01.004_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vascn.2015.02.004","article-title":"Strain echocardiography combined with pharmacological stress test for early detection of anthracycline induced cardiomyopathy","volume":"73","author":"Burdick","year":"2015","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"2\u20133","key":"10.1016\/j.etp.2017.01.004_bib0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ejphar.2011.09.021","article-title":"Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy","volume":"670","author":"Campos","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.etp.2017.01.004_bib0025","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/01.CIR.95.4.766","article-title":"Report of the national heart, lung, and blood institute special emphasis panel on heart failure research","volume":"95","author":"Cohn","year":"1997","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.etp.2017.01.004_bib0030","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1096\/fj.01-0030fje","article-title":"Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury","volume":"15","author":"Danialou","year":"2001","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.etp.2017.01.004_bib0035","first-page":"288","article-title":"Ultrastructural features of Adriamycin-induced skeletal and cardiac muscle toxicity","volume":"118","author":"Doroshow","year":"1985","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.etp.2017.01.004_bib0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3349\/ymj.2005.46.1.73","article-title":"Serial assessment of myocardial properties using cyclic variation of integrated backscatter in an adriamycin-induced cardiomyopathy rat model","volume":"46","author":"Ha","year":"2005","journal-title":"Yonsei Med. J."},{"issue":"4","key":"10.1016\/j.etp.2017.01.004_bib0045","first-page":"20","article-title":"Doxorubicin cardiotoxicity in the rat: an in vivo characterization","volume":"46","author":"Hayward","year":"2007","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"issue":"6","key":"10.1016\/j.etp.2017.01.004_bib0050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3109\/15376516.2013.773391","article-title":"A short-time model to study relevant indices of cardiotoxicity of doxorubicin in the rat","volume":"23","author":"Hole","year":"2013","journal-title":"Toxicol. Mech. Methods"},{"issue":"3","key":"10.1016\/j.etp.2017.01.004_bib0055","first-page":"292","article-title":"An anthracycline antibiotic-induced cardiomyopathy in rabbits","volume":"30","author":"Jaenke","year":"1974","journal-title":"Lab. Invest."},{"issue":"3","key":"10.1016\/j.etp.2017.01.004_bib0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0167-5273(96)02672-1","article-title":"Cardiac energy metabolism at several stages of adriamycin-induced heart failure in rats","volume":"55","author":"Kawasaki","year":"1996","journal-title":"Int. J. Cardiol."},{"issue":"19","key":"10.1016\/j.etp.2017.01.004_bib0065","first-page":"903","article-title":"Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)","volume":"15","author":"Maral","year":"1967","journal-title":"Pathol. Biol."},{"issue":"8 Pt 1","key":"10.1016\/j.etp.2017.01.004_bib0070","first-page":"2705","article-title":"Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats","volume":"37","author":"Mettler","year":"1977","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.etp.2017.01.004_bib0075","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.athoracsur.2004.04.002","article-title":"Animal models of heart failure: what is new?","volume":"79","author":"Monnet","year":"2005","journal-title":"Ann. Thorac. Surg."},{"issue":"3","key":"10.1016\/j.etp.2017.01.004_bib0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00686558","article-title":"Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin","volume":"35","author":"Pouna","year":"1995","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"3","key":"10.1016\/j.etp.2017.01.004_bib0085","first-page":"279","article-title":"Strain analysis in the assessment of a mouse model of cardiotoxicity due to chemotherapy: sample for preclinical research","volume":"30","author":"Rea","year":"2016","journal-title":"In Vivo"},{"issue":"3","key":"10.1016\/j.etp.2017.01.004_bib0090","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/FJC.0b013e3181865f28","article-title":"Effects of angiotensin-1 converting enzyme inhibition on oxidative stress and bradykinin receptor expression during doxorubicin-induced cardiomyopathy in rats","volume":"52","author":"Richard","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.etp.2017.01.004_bib0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12012-007-0022-4","article-title":"Long-term and short-term models for studying anthracycline cardiotoxicity and protectors","volume":"7","author":"Robert","year":"2007","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.etp.2017.01.004_bib0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1476-7120-10-40","article-title":"Early detection of doxorubicin myocardial injury by ultrasonic tissue characterization in an experimental animal model","volume":"10","author":"Romano","year":"2012","journal-title":"Cardiovasc. Ultrasound"},{"issue":"3","key":"10.1016\/j.etp.2017.01.004_bib0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/phrs.2000.0769","article-title":"The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats","volume":"43","author":"Saad","year":"2001","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.etp.2017.01.004_bib0110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0008-6363(98)00009-1","article-title":"A small animal model of non-ischemic cardiomyopathy and its evaluation by transthoracic echocardiography","volume":"39","author":"Schwarz","year":"1998","journal-title":"Cardiovasc. Res."},{"issue":"1\u20132","key":"10.1016\/j.etp.2017.01.004_bib0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1007094214460","article-title":"Adriamycin-induced heart failure: mechanism and modulation","volume":"207","author":"Singal","year":"2000","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.etp.2017.01.004_bib0120","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1161\/01.CIR.89.6.2829","article-title":"Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats","volume":"89","author":"Siveski-Iliskovic","year":"1994","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.etp.2017.01.004_bib0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/cvr\/19.4.181","article-title":"Experimental models of heart failure","volume":"19","author":"Smith","year":"1985","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.etp.2017.01.004_bib0130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.pcad.2006.10.002","article-title":"Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management","volume":"49","author":"Takemura","year":"2007","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.etp.2017.01.004_bib0135","doi-asserted-by":"crossref","first-page":"465342","DOI":"10.1155\/2015\/465342","article-title":"An upgrade on the rabbit model of anthracycline-Induced cardiomyopathy: shorter protocol, reduced mortality, and higher incidence of overt dilated cardiomyopathy","volume":"2015","author":"Talavera","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.etp.2017.01.004_bib0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0002-9149(76)90491-4","article-title":"Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy","volume":"37","author":"Teichholz","year":"1976","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.etp.2017.01.004_bib0145","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1388-9842(00)00111-2","article-title":"Progressive cardiac dysfunction in adriamycin-induced cardiomyopathy rats","volume":"2","author":"Teraoka","year":"2000","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.etp.2017.01.004_bib0150","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00005344-200009000-00012","article-title":"Prevention of doxorubicin (adriamycin)-induced cardiomyopathy by simultaneous administration of angiotensin-converting enzyme inhibitor assessed by acoustic densitometry","volume":"36","author":"Tokudome","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"8","key":"10.1016\/j.etp.2017.01.004_bib0155","first-page":"1283","article-title":"Metaiodobenzylguanidine: evaluation of its potential as a tracer for monitoring doxorubicin cardiomyopathy","volume":"34","author":"Wakasugi","year":"1993","journal-title":"J. Nucl. Med."},{"issue":"9","key":"10.1016\/j.etp.2017.01.004_bib0160","first-page":"1529","article-title":"Myocardial substrate utilization and left ventricular function in adriamycin cardiomyopathy","volume":"34","author":"Wakasugi","year":"1993","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.etp.2017.01.004_bib0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1043-6618(03)00185-3","article-title":"Erdosteine prevents doxorubicin-induced cardiotoxicity in rats","volume":"48","author":"Yagmurca","year":"2003","journal-title":"Pharmacol. Res."}],"container-title":["Experimental and Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940299317300258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940299317300258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T12:42:15Z","timestamp":1656938535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0940299317300258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0940299317300258"],"URL":"https:\/\/doi.org\/10.1016\/j.etp.2017.01.004","relation":{},"ISSN":["0940-2993"],"issn-type":[{"value":"0940-2993","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term and long-term models of doxorubicin-induced cardiomyopathy in rats: A comparison of functional and histopathological changes","name":"articletitle","label":"Article Title"},{"value":"Experimental and Toxicologic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etp.2017.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}